questionText: To ask the Secretary of State for Health and Social Care, in reference to the ongoing reform of Part IX of the Drug Tariff, a) what the objective is of introducing renewed product clusters for products listed on Part IX of the Drug Tariff, b) how his Department plans to ensure all products are placed into clinically interchangeable categories with no unintended consequences to patient care and c) how his Department aims to i) assess and ii) differentiate a product’s value through the categorisation process and enhanced assessment framework.
answerText: The ongoing reform of Part IX of the Drug Tariff is intended to ensure that the system remains clinically appropriate, delivers value for money for the National Health Service, and supports patient access to high-quality medical devices.Previous arrangeme...
heading: Prescription Drugs